1 The effects of angiotensin II (All) and angiotensin III (AIII) on the isolated vas deferens of the guinea-pig were studied via three parameters: the overflow of adenosine 5'-triphosphate (ATP) and tritiated noradrenaline (NA), the mechanical response to field stimulation and the mechanical response to exogenous NA and a,#-methylene ATP (a,#-mATP).
Introduction
The guinea-pig vas deferens has been widely used for the study of the action of co-transmitters. The neurogenic response of the vas deferens is biphasic, consisting of an initial twitch response and a slow second component. This second phase is adrenergic in nature (Swedin, 1971) , whereas the twitch response has been shown to be non-adrenergic, noncholinergic in nature and is due to the release of adenosine 5'-triphosphate (ATP) (Levitt et al., 1984;  Sneddon & Sneddon & Westfall, 1984; Stjarne & Astrand, 1985; Kirkpatrick & Burnstock, 1987; Kasakov et al., 1988) . ATP and noradrenaline (NA) are stored together in storage vesicles of sympathetic nerve terminals (Lagercrantz & Stjarne, 1974; Lagercrantz, 1976; Fried et al., 1978) . ATP release in response to neurogenic stimulation of the guinea-pig vas deferens has been shown in a number of studies (Kirkpatrick & Burnstock, 1 Author for correspondence.
1987; Lew & White, 1987; Kasakov et al., 1988) . ATP which is released originates from sympathetic nerve terminals and its release is blocked by tetrodotoxin (Kirkpatrick & Burnstock, 1987) . ATP release from guinea-pig vas deferens has been shown to be of neuronal origin as release is not affected with the nerves intact and with the mechanical response blocked by a,fl-methylene ATP (a,fl-mATP) and prazosin (Kasakov et al., 1988) , nor is ATP release affected following depletion of NA by reserpine pretreatment, suggesting that ATP release is not secondary to NA release (Kirkpatrick & Burnstock, 1987) .
In the early 1960s, angiotensin II (All) was shown to facilitate adrenergic neurotransmission (McCubbin & Page, 1963; Benelli et al., 1964) . This was shown in the guinea-pig vas deferens to be a direct effect, only facilitating NA release when the nerves were actively firing (Bell, 1972) . More recently, the pharmacological effects of All, and its active metabolite, angiotensin III (des-Asp1-angiotensin II) (AIII), have been studied on purinergic and adrenergic neurotransmission in the rabbit vas deferens (Trachte et al., 1984; Trachte, 1988) . The latter study drew conclusions on ATP and NA release by analysis of the mechanical response of the vas deferens to field stimulation. The purpose of this study was to examine the action of All and AIII on neurotransmission in the guinea-pig vas deferens by directly measuring the release of endogenous ATP and the release of radiolabelled NA. The actions of these substances on the mechanical response to field stimulation and the pharmacological response to exogenously added a,fimATP and NA were also studied.
Methods

General
Male guinea-pigs (250-40 g) were stunned and exsanguinated. The prostatic portions of the vasa deferentia were excised and stripped of connective tissue. Following incubation (60min) with [3H]-NA, the isolated preparations (10-20mg wet weight) were placed between pairs of platinum ring electrodes (15mm apart) and were allowed to equilibrate, with one end tied to the holder and the other attached to a Grass force-displacement transducer (FTO3 C). Contractions were measured as changes in isometric tension by a Washington data recording system. The preparations, at an initial tension of 0.5-1 g, were superfused at a flow rate of 2.5 ml min 1 by use of a Watson-Marlow peristaltic pump with a modified Krebs solution (MKS) (mM: NaCl 133, KCl 4.7, CaCl2 2.5, MgSO4 2.5, NaH2PO4 1.4, NaHCO3 16.3, glucose 7.7 and ascorbic acid 0.1 and gassed continuously with 5% CO2 in 02 at 36°C). After a 90min equilibration period the superfusate was collected, before, during and after stimulation, in polypropylene vials for subsequent determination of (Beattie et al., 1986; Kapocsi et al., 1987) . Hence the evoked efflux of [3H]-NA reflected a quasi-physiological release of NA (Reichenbacher et al., 1982) .
Pharmacological study
Prostatic portions of the vas deferens were tied to tissue holders and placed in 5ml organ baths containing MKS at 36WC and equilibrated for 90min.
After the equilibration period, either NA or a,fimATP at bath concentrations of 30M and 1 M respectively were added for short periods every 15 min. The tissues were washed as soon as a maximum response was reached to prevent desensitization. a,fi-mATP was used as it is a stable analogue of ATP. After establishing control responses to agonists, the angiotensins were added 10min before a further addition of NA or a,#-mATP. Results were calculated as the percentage response to each agonist relative to the previous response when no angiotensins were present.
Analysis ofresults
The effects of the angiotensins were assessed by the comparison of S2/Sj ratios for the experimental data versus S2/S1 ratios for the control data. The results for ATP overflow, [3H]-NA overflow and mechanical responses were evaluated by Student's t test for unpaired observations. Results from the pharmacological study were evaluated by Student's t test for paired observations. In both cases, probability less than 0.05 was considered statistically significant.
Drugs
Angiotensin II, angiotensin III, noradrenaline, ac,flmethylene ATP and luciferin-luciferase were obtained from Sigma. All, AIII and af-mATP were first prepared as stock solutions in distilled water. NA was prepared in a 0.4% ascorbic acid solution to prevent oxidation. Luciferin-luciferase was prepared in sterile water.
Results
Field stimulation
Control responses The contractile response of the vas deferens to electrical field stimulation (EFS) at 2 Hz (stimulation period lasting 2 min) exhibited two distinct phases: an initial twitch response which reached its maximum in 2-3 s and then faded rapidly and a second slow phase which reached its maximum in 10-15 s and whose amplitude slowly decreased, but which lasted for the duration of the stimulation period. The second stimulation period, 30 min later, exhibited similar contractions but both phases were slightly reduced in amplitude (S2/S1 ratio for 1st phase was 0.81 + 0.09, 2nd phase was shown by comparing the control S2/S1 ratio when no drug is present throughout the experiment to the S2/S1 ratio obtained when the drug is added to the superfusate 15min before the second stimulation. (a) Overflow at 2Hz in the presence of All (100nM) Significance of drug effects were assessed by using Student's t test for unpaired observations (**P < 0.01, ***P < 0.001).
Angiotensin II The addition of angiotensin II (All) (100nM) to the superfusate 15 min before the second stimulation had no effect on the baseline tension of the preparations. At 2 Hz, when compared to the control values, All enhanced both phases of the response. The S2/S1 ratio for the purinergic phase of the response was 1.06 + 0.07 (n = 8) (Figure 3a ) and for the adrenergic phase it was 1.09 + 0.09 (n = 6) ( Figure 3b ). All at this frequency also enhanced, relative to the second control stimulation, the stimulus-evoked overflow of both [3H]-NA (S/S1 ratio was 1.72 + 0.19, n = 6) ( Figure 2a ) and of ATP (S2/S1 ratio was 0.80 + 0.06, n = 6) (Figure la) . At 20Hz, All enhanced the magnitude of the response (S251 ratio was 1.15 + 0.04, n = 6) (Figure 3c ). At this frequency, All enhanced the overflow of [3H]-NA (S2/51 ratio was 1.54 + 0.16, n = 6) ( Figure 2b) ; however, compared to controls it was without significant effect on ATP overflow (S2/51 ratio was 0.99 + 0.13, n = 6) (Figure lb).
Angiotensin III Angiotensin III (AIII) (100 nM) did not affect the baseline tension of the preparations. At 2 Hz, compared to controls, AIII significantly enhanced the adrenergic phase of the response (S2/S, ratio was 1.00 + 0.04, n = 6) ( Figure 3b) ; however, it Each column is the mean of at least six observations and vertical lines indicate s.e.mean. Significance of drug effects were assessed by Student's t test for unpaired observations (NS = not significant, *P < 0.05).
was without significant effect on the fast initial purinergic phase (S/S1 ratio was 0.90 + 0.03, n = 6) ( Figure 3a (100nM) (Figure 4 ).
Discussion
Interpretation of these results shot account pre-and postjunctional interg ATP and adenosine, resulting from c breakdown of ATP. There is also the an interaction with the neuromod peptide Y (NPY). NPY is known to cc and ATP (Fried et al., 1985; to be released along with NA and AT] lation of sympathetic nerves of the l deferens (Kasakov et al., 1988 (Stjarne & Lundberg, 1986) . It is therefore possible that the angiotensins, by affecting the release of NPY, may NS have subsequent effects on NA and ATP release and their postjunctional effects. Confirmation of any involvement of NPY will have to await a study on .
the effect of angiotensins on NPY release. There is also a possible interaction with the autoinhibition by adenosine and NA itself. Adenosine is known to inhibit the release of both ATP and NA (Sneddon et -.-. al., 1984) , whereas NA inhibits its own release (see Starke, 1987) . The biphasic nature of the response and the concomitant release of both [3H]-NA and endogenous .
ATP confirms previous studies that the response of this tissue to field stimulation is due to NA and ATP C All AMil acting as co-transmitters (see Burnstock, 1982; Burn- (Trachte et al., 1984) . However, these studies deduced angiotensin effects on release by the indirect method of analysing pharmacological studies which All (100 nM) have the inherent problems of pre-and postjunction-4A produced a al interactions. Neither in this paper nor in a later alue 109 + 3% study (Trachte, 1988) (Saye et al., 1986; Trachte, 1988) . The latter study, as in the present study, showed that at 2 Hz the angiotensins enhanced the adrenergic phase of the response. However the reported inhibition of the purinergic phase by both of the angiotensins was not repeated in this study, although AIII has been shown to inhibit the overflow of ATP. Saye et al. (1986) reported that at low frequencies All potentiated both phases of the response as is seen in the present study, whereas AIII inhibited both phases of the response. Interestingly, Saye et al. (1986) found that the inhibition by AIII was turned into a potentiation in the presence of indomethacin. As both studies mentioned used the same tissue and stimulation parameters it is difficult to explain the discrepancy. We conclude that All and AIII have opposing actions on ATP release at low frequency. This is probably due to an action at different angiotensin receptors situated prejunctionally (Trachte et al., 1984; Trachte, 1988 (Magnan & Regoli, 1979; Boke & Malik, 1983; Trachte, 1988) and at low and high frequencies (Zimmerman et al., 1972) . By measuring [3H]-NA release, our study shows that facilitation of adrenergic transmission by angiotensins can be attributed to an increase in the amount of NA released and is not due to a postjunctional action.
The lack of effect of the angiotensins on the resting tension suggests that the angiotensins, at least at the concentrations used, are without direct effect on the smooth muscle of the vas deferens.
The reason for the disparate effects of angiotensins on ATP and NA release is unclear. It is possible that in the vas deferens there are nerves that are predominantly purinergic and those that are predominantly adrenergic. This hypothesis could also be used to explain the observation that adrenergic transmission is predominant at the epidymal end and purinergic transmission is predominant at the prostatic end of the rodent vas deferens (McGrath, 1978; Rohde et al., 1986) . On the other hand, NA and ATP are known to be stored in small dense-cored vesicles and in large vesicles (Lagercrantz & Stjarne, 1974; Lagercrantz, 1976; Fried et al., 1978) , and so a neuromodulator may alter release from one type of vesicle in one way and the release from another type in another. Also the ratio of small vesicles to large vesicles may vary, as may the ratio of catecholamine to ATP in the vesicles within different nerves or even within the same nerve terminal. Large vesicles may contain both ATP and NA or there may be vesicles containing only NA and vesicles containing only ATP, as has been suggested for NPY and NA storage (Fried et al., 1985) .
In summary, angiotensins were found to have differing actions at low frequency and no effect at high frequency on purinergic transmission in the guineapig vas deferens. In contrast, both angiotensins enhance adrenergic transmission at low and high frequency. This action is predominantly prejunctional as shown by the direct method of measurement of release of transmitters, although All also facilitates transmission postjunctionally. The different actions of the angiotensins suggests that they are acting prejunctionally on different receptor subtypes, with different affinities for All and AIII. The opposing effects on purinergic and adrenergic transmission by the angiotensins suggest that ATP and NA storage and/or release are not similar in the guinea-pig vas deferens. This is borne out by the finding that ATP neuromodulation by angiotensins is frequencydependent, whereas NA modulation is not. Our results provide the first direct evidence of the effects of angiotensins on both ATP and NA release and the role of frequency of stimulation on neuromodulation.
